Chambers Review
Provided by Chambers
Email address
[email protected]Contact number
86 10 8519 1718Share profile
Band 5
Provided by Marissa Dong
Ms Dong is an experienced lawyer with a focus on telecom and internet, technology, data privacy, information law, and general corporate matters. With over two decades of practice, she began her career in corporate and M&A law, guiding inbound investors through all stages of operations in China, from market entry and business expansion through setting up new presence or acquisitions.
With an interest in technology, Ms Dong has developed a deep understanding of new business models and technology and is one of the pioneer practitioners that expertise in digitalization and data protection in China more than 10 years ago. During her years of practice, she has assisted various retail and ecommerce companies, telecom and Internet companies, and companies in other industries with a need of digitalization in ways of platforms, apps, mini-programs or other online channels to build up and operate their services in China. She advises them from licenses and permits, data compliance, cross-border data transfer, arrangements with vendors and partners, and various issues throughout different operational stages.
By supporting clients in their operations in China, Ms. Dong has not only gained substantial experience in dealing with complex commercial transactions but also a deep understanding of the law and its implementation, government policies and the business environment, which enables her to assist clients to set up sensible strategies and explore practical approaches to doing business. She also helps clients with overseas data compliance such as GDPR and CCPA compliance alongside overseas lawyers.
Ms. Dong is a member of the All-China Bar Association.
Marissa has made significant contributions to the legal field through her writings, presentations, and participation in industry events. She has authored chapters in books such as "Global Privacy and Security Law" and "The Privacy, Data Protection and Cybersecurity Law Review." She has also contributed to publications such as "Chinese Civil Code: Privacy and Personal Information Protection," "Data Protection in China," and "Privacy in China: Overview." Her articles have been published on Thomson Reuters Practical Law, covering topics such as Chinese Civil Code, privacy, and personal information protection. She has also published handbooks and guides on data protection and contributed to industry-specific publications.
Provided by Chambers
Provided by Chambers
Marissa Dong is very pragmatic in her advice and gives us good market intelligence and benchmarking, not just reading the black-and-white laws.
董潇律师的建议非常实用,并为我们提供了良好的市场情报和基准,并不拘泥于为我们阅读非黑即白的法律条款。
Marissa Dong is very pragmatic in her advice and gives us good market intelligence and benchmarking, not just reading the black-and-white laws.
董潇律师的建议非常实用,并为我们提供了良好的市场情报和基准,并不拘泥于为我们阅读非黑即白的法律条款。
6 items provided by JunHe LLP
JunHe Recognized in the Boutique Legal Service Brands Guide 2024: Data Compliance
On June 30, 2024, the 2024 Legal Vision Data Compliance Forum with the theme “Follow the Rules - Data to the Future” was held in Shanghai, at which Legal Vision released its Boutique Legal Service Brands Guide 2024: Data Compliance (the “Guide”).
JunHe Advises Changjiu Holdings on its Listing on the Main Board of the HKEx
On January 9, 2024, Changjiu Holdings Limited (“Changjiu Holdings”) was successfully listed on the Main Board of the Stock Exchange of Hong Kong Limited (the “HKEx”).
JunHe helps QuantumPharm become the first to list on HKEX under new Chapter 18C rules
On 13 June 2024, QuantumPharm Inc. was listed on the Main Board of the Hong Kong Stock Exchange. QuantumPharm is the first stock to be listed under Chapter 18C of the New Rules Governing the Listing of Specialized Technology Companies on the Hong Kong Stock Exchange.
JunHe Assists Black Sesame in its Listing on the Main Board of the Hong Kong Stock Exchange
Black Sesame (2533.HK) listed on the Hong Kong Stock Exchange on August 8, 2024, under Chapter 18C, raising HK$1.036 billion with a share offer of 37 million at HK$28. It's the first smart driving chip company to list there.
JunHe facilitates ImmuneOnco and Instil Bio's licensing and cooperation agreement
On August 1, 2024, ImmuneOnco and Instil Bio agreed that Instil will license ImmuneOnco's PD-L1xVEGF bispecific antibody IMM2510 and anti-CTLA-4 antibody IMM27M for development and commercialization outside China.
JunHe Assists Dongying in the Court Approval of its Reorganization Plan
On Oct 24, 2024, Shanghai Dongying Real Estate's reorganization plan was approved by the People's Court of Pudong New Area. JunHe's Shanghai office, led by partner Liu Zhengdong, served as the reorganization administrator, aiding Dongying in ensuring timely presold home deliveries.
JunHe Recognized in the Boutique Legal Service Brands Guide 2024: Data Compliance
On June 30, 2024, the 2024 Legal Vision Data Compliance Forum with the theme “Follow the Rules - Data to the Future” was held in Shanghai, at which Legal Vision released its Boutique Legal Service Brands Guide 2024: Data Compliance (the “Guide”).
JunHe Advises Changjiu Holdings on its Listing on the Main Board of the HKEx
On January 9, 2024, Changjiu Holdings Limited (“Changjiu Holdings”) was successfully listed on the Main Board of the Stock Exchange of Hong Kong Limited (the “HKEx”).
JunHe helps QuantumPharm become the first to list on HKEX under new Chapter 18C rules
On 13 June 2024, QuantumPharm Inc. was listed on the Main Board of the Hong Kong Stock Exchange. QuantumPharm is the first stock to be listed under Chapter 18C of the New Rules Governing the Listing of Specialized Technology Companies on the Hong Kong Stock Exchange.
JunHe Assists Black Sesame in its Listing on the Main Board of the Hong Kong Stock Exchange
Black Sesame (2533.HK) listed on the Hong Kong Stock Exchange on August 8, 2024, under Chapter 18C, raising HK$1.036 billion with a share offer of 37 million at HK$28. It's the first smart driving chip company to list there.
JunHe facilitates ImmuneOnco and Instil Bio's licensing and cooperation agreement
On August 1, 2024, ImmuneOnco and Instil Bio agreed that Instil will license ImmuneOnco's PD-L1xVEGF bispecific antibody IMM2510 and anti-CTLA-4 antibody IMM27M for development and commercialization outside China.
JunHe Assists Dongying in the Court Approval of its Reorganization Plan
On Oct 24, 2024, Shanghai Dongying Real Estate's reorganization plan was approved by the People's Court of Pudong New Area. JunHe's Shanghai office, led by partner Liu Zhengdong, served as the reorganization administrator, aiding Dongying in ensuring timely presold home deliveries.